India’s Panacea Biotec partners with US firm to make Covid-19 vaccine
Team Udayavani, Jun 12, 2020, 12:05 PM IST
Indian biotech firm Panacea Biotec Ltd will partner with U.S.based Refana Inc to make a potential vaccine for Covid-19
Under the partnership, Panacea Biotec will be responsible for product development and commercial manufacturing of an inactivated virus-based vaccine
The collaboration aims to make more than 500 million doses of the vaccine candidate, with over 40 million doses expected to be available early next year.
The company said that after the CGMP process, the first phase of the human trial will be held by October and they will be able to conduct the third phase of the trial on a large scale.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Deep-tech drives growing patenting patterns in India; highest filings in Tamil Nadu: Study
Don’t blame Dubai’s freak rain on cloud seeding
ISRO Gears Up to Test Critical Parachute Safety of Gaganyaan
Indian students bag NASA awards for Human Exploration Rover Challenge
‘Mastering the Data Paradox’: Book uncovers pivotal role of data in AI age
MUST WATCH
Latest Additions
Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business
Congress to discuss candidates for Amethi, Raebareli seats on Saturday
BJP’s CT Ravi Booked for Promoting Hatred and Enmity Through Social Media Post
Elections held in 14 LS segments in Karnataka, voter turnout nearly 64 per cent till 5 pm
‘PM is scared, may even shed tears on stage’: Rahul Gandhi’s fresh salvo at Modi